Polyrizon seeks FDA designation for viral blocker
Ticker: PLRZ · Form: 6-K · Filed: Dec 19, 2025 · CIK: 1893645
| Field | Detail |
|---|---|
| Company | Polyrizon Ltd. (PLRZ) |
| Form Type | 6-K |
| Filed Date | Dec 19, 2025 |
| Risk Level | medium |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: FDA, medical-device, regulatory-filing
TL;DR
Polyrizon files with FDA for PL-16 Viral Blocker to fight flu/cold viruses.
AI Summary
Polyrizon Ltd. announced on December 19, 2025, that it has submitted a pre-request for designation to the U.S. Food and Drug Administration (FDA) for its PL-16 Viral Blocker. This device is designed to reduce exposure to influenza and cold viruses. The company is a foreign private issuer incorporated in Israel and operates in the surgical and medical instruments sector.
Why It Matters
This FDA submission is a crucial step for Polyrizon Ltd. as it moves its PL-16 Viral Blocker closer to potential market approval, which could impact the availability of new tools for combating common respiratory viruses.
Risk Assessment
Risk Level: medium — The company is in the early stages of seeking FDA designation, and market approval is not guaranteed, introducing regulatory and commercialization risks.
Key Players & Entities
- Polyrizon Ltd. (company) — Filer of the report and developer of the PL-16 Viral Blocker.
- PL-16 Viral Blocker (product) — The device for which Polyrizon is seeking FDA designation.
- U.S. Food and Drug Administration (FDA) (company) — Regulatory body to which Polyrizon submitted its pre-request.
- December 19, 2025 (date) — Date of the press release and submission.
FAQ
What is the specific purpose of the PL-16 Viral Blocker?
The PL-16 Viral Blocker is designed to reduce exposure to influenza and cold viruses.
What action has Polyrizon Ltd. taken regarding the PL-16 Viral Blocker?
Polyrizon Ltd. has submitted a pre-request for designation to the FDA for the PL-16 Viral Blocker.
When was the press release regarding this submission issued?
The press release was issued on December 19, 2025.
What is Polyrizon Ltd.'s SIC code and industry?
Polyrizon Ltd.'s SIC code is 3841, and its industry is SURGICAL & MEDICAL INSTRUMENTS & APPARATUS.
Under which form does Polyrizon Ltd. file its annual reports?
Polyrizon Ltd. files its annual reports under cover of Form 20-F.
Filing Stats: 278 words · 1 min read · ~1 pages · Grade level 13.4 · Accepted 2025-12-19 08:23:10
Filing Documents
- ea0270340-6k_polyrizon.htm (6-K) — 11KB
- ea027034001ex99-1_polyrizon.htm (EX-99.1) — 17KB
- 0001213900-25-123520.txt ( ) — 28KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Polyrizon Ltd. Date: December 19, 2025 By: /s/ Tomer Izraeli Name: Tomer Izraeli Title: Chief Executive Officer 2